Clinical Trials Browser

OTHER × Poly(ADP-ribose) Polymerase Inhibitors × Thoracic × Clear all

NCT05392686 2022-05-26

PD1 and PARP for Maintenance Therapy in NSLLC

Phase 2 Unknown

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT03227016 2021-01-27

Study in Patients With SCLC of Veliparib in Combination With Topotecan

Phase 1 Unknown

Small Cell Lung Carcinoma